Avalo Therapeutics (AVTX) Receivables - Other (2016 - 2024)
Avalo Therapeutics (AVTX) reported Receivables - Other of $611,000 for Q4 2024, up 349.3% from $136,000 a year earlier but down 38.8% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Receivables - Other (2016 - 2024) Analysis & Trends
Dating back to Q2 2016, Avalo Therapeutics' Receivables - Other record includes 28 quarters.
- Receivables - Other has a five-year compound annual growth rate of -32.1% (FY2019 to FY2024).
- By year, Receivables - Other came in at $136,000 in FY2023 (-92.9%), $1.92 million in FY2022 (-48.7%), $3.74 million in FY2021 (+69.3%) and $2.21 million in FY2020 (-47.9%).
- Five-year quarterly Receivables - Other spans a low of -$100,000 in Q1 2024 and a high of $4.29 million in Q3 2020.
- Year over year, Receivables - Other gained in two of the last six quarters, with growth averaging 16.3%.
- The high point for year-over-year Receivables - Other in five years was Q4 2024 (growth of 349.3%); the low point was Q2 2023 (a decline of 99.5%).
- Per Business Quant data, the three quarters before Q4 2024 came in at $998,000 (Q3 2024), -$100,000 (Q2 2024) and -$100,000 (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Avalo Therapeutics | 386.09 Mn | -587.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 611,000.00 |
| Sep 30, 2024 | 998,000.00 |
| Jun 30, 2024 | -100,000.00 |
| Mar 31, 2024 | -100,000.00 |
| Dec 31, 2023 | 136,000.00 |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 857,000.00 |
| Dec 31, 2022 | 1.92 Mn |
| Sep 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Mar 31, 2022 | 1.45 Mn |
| Dec 31, 2021 | 3.74 Mn |
| Sep 30, 2021 | 2.48 Mn |
| Jun 30, 2021 | 998,000.00 |
| Mar 31, 2021 | 2.06 Mn |
| Dec 31, 2020 | 2.21 Mn |
| Sep 30, 2020 | 4.29 Mn |
| Jun 30, 2020 | 1.95 Mn |
| Mar 31, 2020 | 2.06 Mn |
API Access
Avalo Therapeutics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();